Clin2
NCT07139106Possibly a fitNot yet recruiting

Ketamine for suicidal thoughts in depression

Major Depressive Disorder (MDD)

Treatments studied

Part of Mental health clinical trials.

This study tests whether ketamine can help reduce suicidal thoughts in people with depression. It also looks at how ketamine affects a brain receptor that may be linked to mood and stress, to learn why it might help.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
12 people
Ages
18 years to 59 years
Study type
Interventional

Who can take part

  • You must have a current major depressive episode (unipolar depression).
  • You must not have ever misused or been dependent on ketamine.
  • You must not have certain heart rhythm problems or uncontrolled high blood pressure.
  • You must not have bipolar disorder, schizophrenia, or schizoaffective disorder.
  • You must not have used antidepressants in the last 14 days (or 6 weeks for fluoxetine), or benzodiazepines in the last day.
  • You must not be pregnant, planning pregnancy, or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06788249Recruiting· Early Phase 1
Ketamine for treatment-resistant depression brain study

This trial tests whether a single dose of ketamine can quickly improve depression by studying brain chemical changes using MRI. It's for people with treatment-resistant depression who haven't used ketamine before.

Philadelphia, Pennsylvania
NCT06891300Recruiting· Phase 2/Phase 3
Ketamine for Suicidal Thoughts in Depression

This study tests if ketamine can help reduce suicidal thoughts in people with major depression. You'll receive ketamine treatment and be monitored closely.

Ottawa, Ontario
NCT07569198Recruiting· Phase 2
Ketamine plus therapy for depression with suicidal thoughts

This study tests whether ketamine (a medication) combined with a specific type of therapy called DBT can help people with treatment-resistant depression and borderline personality disorder who are having thoughts of suicide. You would receive ketamine infusions alongside structured therapy sessions over 6 months.

Toronto, Ontario
NCT07801703Not yet recruiting· Phase 2/Phase 3
Ketamine and therapy for treatment-resistant depression

This study combines behavioral activation therapy (a type of counseling that helps you re-engage in positive activities) with ketamine infusions to treat depression that hasn't improved with standard antidepressants. The goal is to see if adding this therapy makes ketamine work better and last longer.

Ottawa, Ontario
NCT06213324Recruiting· Phase 4
Ketamine's effects on brain circuits in depression

This trial studies how ketamine affects brain circuits in people with depression compared to healthy volunteers. It involves a single infusion of ketamine and brain scans before and after.

New York, New York
NCT06559826Recruiting· Phase 2
Ketamine therapy with or without talk for depression

This study compares ketamine alone to ketamine combined with psychotherapy for treating depression. It may help if you have moderate to severe depression and want to see if adding talk therapy improves results.

New York, New York

Hear when a new Major Depressive Disorder (MDD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.